Acrivon Therapeutics, Inc. Deferred Offering Costs
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2026-03-19
- 2025-12-31: Deferred Offering Costs $500.00K.
- 2024-12-31: Deferred Offering Costs $500.00K.
- 2023-12-31: Deferred Offering Costs $300.00K.
- 2021-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2025-12-31 | $500.00K 10-K · filed 2026-03-19 |
| 2024-12-31 | $500.00K 10-K · filed 2025-03-27 |
| 2023-12-31 | $300.00K 10-K · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-28 |